Genentech demonstrates how pharma brands can reach younger patient communities with esports

Stephen Whiteside

Genentech, the pharma company, successfully used esports to connect with teenagers and young adults in the US with hemophilia, a rare disorder that reduces the ability of blood to clot.

This article is part of the May 2021 Spotlight US series, "How the pandemic has changed US healthcare marketing." Read more

Genentech is a biotechnology company on the forefront of treating people with hemophilia, a medical condition that significantly reduces the ability of blood to clot, through its Hemlibra brand of prescription medicine.

Learn more Get a demo